Aristotle University Of Thessaloniki (AUTH)
Μελέτη της μικροκυκλοφορίας σε ασθενείς με συστηματικό ερυθηματώδη λύκο
Abstract
dc:descriptionSystemic lupus erythematosus (SLE) is a chronic heterogenous autoimmune disease with a variety of manifestations. It mainly affects women of reproductive age, resulting in a female to male ratio of approximately 9:1. It is characterized by periods of flares and remission, with a diverse clinical course. Despite the marked improvements in SLE therapeutics during the last decades, the disease still has an increased mortality. Moreover, SLE patients have increased cardiovascular (CV) morbidity and mortality. Ιt has been clearly demonstrated that traditional risk factors contribute significantly, nevertheless they cannot solely explain the increased CV burden of these patients. Indeed, patients with SLE exhibit subclinical macrovascular dysfunction (increased arterial stiffness and accelerated subclinical atherosclerosis) compared to healthy controls. Microvascular dysfunction is currently considered an important component of the pathophysiology of CV disease, even from the early stages when no clinically detectable complications are observed. In spite of the recent research advances in autoimmune diseases, there is still some obscurity regarding the presence of microvascular dysfunction in SLE. The aim of this dissertation was to, non-invasively, assess the structural, as well as functional microvascular alterations in SLE in various vascular beds. To this end, a thorough approach was followed by simultaneously evaluating distinct target organs. Patients who met the Systemic Lupus International Collaborating Clinics classification criteria for SLE were recruited. The diagnosis of SLE was made by a rheumatology specialist. The control group consisted of individuals matched for age and body mass index and hypertension history, without serious comorbidities. A complete medical history was obtained, and a physical examination was performed. Blood samples for laboratory tests were obtained. To evaluate microcirculation all participants, additionally, underwent: i) Evaluation of skin microvascular perfusion using laser speckle contrast analysis. Cutaneous blood flow was recorded during a 3-minute baseline, a 5-minute arterial occlusion, and a 5-min reperfusion period. Results are presented as mean perfusion during baseline, percentage decrease of perfusion from baseline to maximum occlusion, mean perfusion at the maximum and percentage increase of perfusion from baseline to the maximum post-occlusive response. ii) Fundoscopy using a non-mydriatic fundus camera to evaluate retinal vessel diameter. Consequently, the images were analysed using a specifically designed semiautomated computer software, to calculate central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE) and arteriovenous ratio (AVR). iii) Indirect assessment of myocardial perfusion through Subendocardial viability ratio (SEVR), using radial artery applanation tonometry. iv) Evaluation of urinary albumin excretion as determined by urine albumin-to-creatinine ratio (UACR) in a random urine sample. In a subgroup of participants evaluation of cerebral oxygenation during isometric handgrip exercise was performed. The protocol involved a seated rest, a 3-min submaximal handgrip exercise (at 30% of their maximal voluntary contraction), and a 3-min recovery. Beat-by-beat haemodynamics were continuously monitored. In addition, continuous near-infrared-spectroscopy was used to monitor changes in cerebral-oxygenated (O2Hb), de-oxygenated (HHb) and total-haemoglobin (tHb) during the protocol. In total, 124 individuals (54 SLE patients and 70 controls) aged 46.0 ± 10.4 years were included in the study, 80.6% of whom were women. By study design, no statistically significant differences were observed regarding demographic and somatometric characteristics. It is also worth mentioning that one out of three (33.3%) SLE patients were in remission or low disease activity state. The results revealed that patients with SLE demonstrated impaired skin microvascular reactivity compared to the control group (162.5 ± 43.0 vs 196.8 ± 42.2 respectively, p<0.001). Moreover, patients with SLE exhibited a significantly lower average- response in O2Hb (1.14 ± 0.84 vs 2.76 ± 2.44 respectively, p<0.001), and a lower peak- O2Hb response (2.88 ± 1.56 vs 5.83 ± 4.59 respectively, p=0.002) compared to non-SLE peers. The SLE group maintained, also, significantly lower average- and peak tHb than controls, while no differences were detected in the HHb responses between the groups. In addition, individuals in the SLE group presented retinal arteriolar narrowing (CRAE 87.2 ± 11.0 vs 94.6 ± 13.3 respectively, p=0.004), whereas no statistically significant differences were observed in CRVE or AVR. Most importantly, when we examined separately participants free of any CV comorbidities, the dysfunction of microcirculation was still present as compared to healthy individuals. On the other hand, SEVR did not differ between the two groups. Regarding urinary albumin excretion, patients with SLE exhibited significantly higher UACR levels compared to controls [9.8 (5.4 – 26.5) vs 6.0 (5.0 – 7.6) respectively, p=0.021]. However, the results did not remain statistically significant when we excluded individuals with a history of lupus nephritis [6.1 (5.3 – 12.2) vs 6.0 (5.0 – 7.6) respectively, p=0.295]. Finally, an attempt to investigate the prevalence of microvascular alterations in SLE was performed. It was shown for the first time that two out of three SLE patients (66.7% in the whole population and 61.8% in individuals without CV disease or risk factors) presented at least one microvascular target organ dysfunction. This finding can be further translated into a greater chance for SLE patients of microvascular dysfunction compared to controls (OR:8.0 95% CI: 3.5 – 18.1), even without any CV comorbidities (OR:7.7 95% CI: 2.8 – 20.9). Interestingly, statistically significant percentage of the SLE individuals presented microvascular dysfunction in at least two target organs compared to controls (18.5% vs 1.4% respectively, p<0.001). Of the examined target organs, the brain and the skin appeared to be mostly affected. Only one out of three SLE patients (33.3% in the whole population and 38.2% in individuals without CV disease or risk factors) was free from any form of microvascular organ damage. In conclusion, patients with SLE, even those without CV disease or risk factors, exhibited microvascular dysfunction. The observed microvascular dysfunction in SLE may partially explain the increased CV risk that these patients bare. Evaluation of microcirculation in SLE patients could assist in the early identification of a more generalised microvascular damage. However, larger studies are needed to confirm these results, to explore possible underlying mechanisms and prognostic factors as well as to identify associations with other well-established micro- or macrocirculation indices.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koletsos-Soultis, Nikolaos
- Κολέτσος-Σούλτης, Νικόλαος
Subjects
dc:subject × 17- Συστηματικός ερυθηματώδης λύκος (ΣΕΛ)
- Μικροκυκλοφορία
- Μικροαγγειοπάθεια
- Εγκεφαλική οξυγόνωση
- Ισομετρική άσκηση
- Systemic lupus erythematosus ( SLE)
- Microcirculation
- Microvascular dysfunction
- Laser speckle contrast analysis
- Brain oxygenation
- Exercise
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ρευματολογία
- Clinical Medicine
- Medical and Health Sciences
- Rheumatology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53699